Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News IM Cannabis Corp C.IMCC

Alternate Symbol(s):  IMCC

Healthcare
IM Cannabis Corp. is a Canada-based medical cannabis company. The Company operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), which has a cultivation license to breed, grow and supply medical cannabis products in Israel. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in... see more

Recent & Breaking News (CSE:IMCC)

IM Cannabis to Report Second Quarter 2022 Financial Results on Monday, August 15 at 9:00am ET

PR Newswire August 4, 2022

IM Cannabis Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

PR Newswire July 19, 2022

The Flowr Corporation Announces Fourth Quarter and Full Year 2021 Results

GlobeNewswire May 20, 2022

IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million

PR Newswire May 12, 2022

IM Cannabis to Report First Quarter 2022 Financial Results on Thursday, May 12 at 5:00 p.m. ET

PR Newswire May 5, 2022

OREN SHUSTER ACQUIRES COMMON SHARES OF IM CANNABIS CORP.

PR Newswire April 12, 2022

IM Cannabis Strengthens Focus on Importing Premium and Ultra-Premium Products from its Canadian Subsidiaries

PR Newswire April 6, 2022

IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook

PR Newswire March 31, 2022

IM Cannabis Closes Previously Announced Acquisition of Oranim Pharm, Jerusalem's Leading Medical Cannabis Pharmacy

PR Newswire March 30, 2022

IM Cannabis Reschedules Fourth Quarter and Full Year 2021 Conference Call to Thursday, March 31 at 9:00 a.m. ET

PR Newswire March 29, 2022

IM Cannabis to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, March 30 at 9:00 a.m. ET

PR Newswire March 23, 2022

IM Cannabis Closes Three Previously Announced Strategic Acquisitions in Israel

PR Newswire March 15, 2022

IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results

PR Newswire March 10, 2022

IM Cannabis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

PR Newswire February 8, 2022

IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel

Accesswire January 19, 2022

The Flowr Corporation Announces International Commercialization of Its Flagship Strains - BC Black Cherry and BC Strawnana

GlobeNewswire January 13, 2022

IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company's Israeli Subsidiary

Accesswire January 13, 2022

IM Cannabis to Launch WAGNERS Brand in Germany

Accesswire December 7, 2021

IM Cannabis to Acquire Oranim, Jerusalem's Leading Medical Cannabis Pharmacy

Accesswire December 1, 2021

IM Cannabis Announces Focus Medical's Receipt of Israeli Ministry of Health Import Permit; Plans to Launch WAGNERS Brand in Israel

Accesswire November 29, 2021